I didn’t know either and found it very encouragi
Post# of 72440
After reading the description of the EOP2 meeting on the FDA website I came to understand - and believe! - two things:
1) The FDA already has all of the information to be discussed at the meeting
2) The meeting wouldn’t have been scheduled if there was going to be a problem.
It looks like the meeting is done to iron out the trial details and for the FDA to wiegh in on HOW to proceed, not IF.
I realize anything can happen, but it’s looking good.